Aspen Pharmacare Holdings Ltd banner

Intrinsic Value

The intrinsic value of Aspen Pharmacare Holdings Ltd (LDZA) under the Base Case is 5.41 EUR per share. Compared with the current market price of 9.4 EUR, the stock appears Overvalued by 42% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

LDZA Intrinsic Value
€5.41
Overvaluation 42%
Intrinsic Value
Price €9.4
Alert me when LDZA is below its intrinsic value
Today €4.32 · 54.0% below the current price

LDZA is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to LDZA

Fundamental Analysis

What Aspen Pharmacare Does

Pharmaceuticals Health Care

Aspen Pharmacare is a pharmaceutical company that makes and sells medicines, mainly branded and generic prescription drugs, injectables, and other hospital-focused products. It also has manufacturing capabilities that support third-party production in some cases. The company serves pharmacies, hospitals, governments, wholesalers, and other healthcare buyers that need reliable supply of essential medicines.

Headquarters
South Africa ZA
Employees
9 128
IPO date
Dec 5, 1994
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Aspen Pharmacare Holdings Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one LDZA stock?

The intrinsic value for Aspen Pharmacare Holdings Ltd (LDZA) under the Base Case is 5.41 EUR.

Is LDZA stock undervalued or overvalued?

Compared with the current market price of 9.4 EUR, the stock appears Overvalued by 42% .

Back to Top